TB
Todd Bauer
Physician · OneOncology
Credentials: · · · ·
History
- Present
- 2008–2011
Ohio State University-Hem / Onc


Research
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
New England Journal of Medicine · 2020 · 933 citations
Cancer Discovery · 2015 · 652 citations
Cancer Discovery · 2017 · 648 citations

20 papers

17 papers
- JB
12 papers
- JI
10 papers

9 papers

9 papers
- GF
8 papers
- HB
7 papers


